Vermont Adopts Appriss' Platform to Mitigate Drug Diversion
11 janv. 2016 11h05 HE
|
Appriss
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont...
Ohio Selects Appriss' PMP Gateway to Enhance Interoperability of OARRS Platform
01 déc. 2015 10h49 HE
|
Appriss
LOUISVILLE, Ky., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that is has signed an...
Palmetto Health Takes Steps to Prevent Prescription Drug Abuse
09 nov. 2015 10h31 HE
|
Appriss
LOUISVILLE, Ky., Nov. 9, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) calls the misuse and abuse of prescription medications a nationwide epidemic. According to the...
South Carolina Awards Contract to Appriss for New Prescription Monitoring Solution
16 sept. 2015 11h06 HE
|
Appriss
LOUISVILLE, Ky., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of South...
Kroger Introduces Appriss' NARxCHECK(TM) into Pharmacies
12 août 2015 11h51 HE
|
Appriss
LOUISVILLE, Ky., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that The Kroger Co. has...
Cerner Integrates NARxCHECK(TM) Into Electronic Health Record System
06 août 2015 10h30 HE
|
Appriss
LOUISVILLE, Ky., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that Cerner (Nasdaq: CERN),...
South Dakota Adopts Appriss Platform to Mitigate Drug Diversion
01 juil. 2015 12h12 HE
|
Appriss
LOUISVILLE, Ky., July 1, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of South...
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
22 avr. 2014 07h41 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 8,703,186 titled...
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
02 mars 2012 06h30 HE
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Mar 2, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced independent laboratory...
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
17 oct. 2011 06h00 HE
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...